Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Neumora Therapeutics INC. (NMRA)

111 + Investors. Track Smart Money conviction in NMRA. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +12
Streak
2Q ▲
Buyers last Q
56%

Smart Money Signals — NMRA

Based on 111 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds added NMRA than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
📊

High ownership — 78% of 3.0Y peak

78% of all-time peak
111 funds currently hold this stock — 78% of the 3.0-year high of 142 funds (reached 2024 Q4). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
〰️

Stable — ownership unchanged year-over-year

fund count last 6Q
The number of hedge funds holding NMRA is almost the same as a year ago (-4 funds, -3% change). No significant rush to buy or sell — institutional backing is holding steady.
🟡

Slight buying edge — 56% buying

59 buying46 selling
Last quarter: 59 funds bought or added vs 46 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
➡️

Steady new buyers — ~24 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 24 → 15 → 22 → 24. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
📌

Mixed — 30% long-term, 31% new

■ 30% conviction (2yr+) ■ 40% medium ■ 31% new
Of the 111 current holders: 33 (30%) held >2 years, 44 held 1–2 years, and 34 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.
📈

Growing discovery — still being found

33 → 24 → 15 → 22 → 24 new funds/Q
New funds entering each quarter: 24 → 15 → 22 → 24. A growing number of institutions are discovering NMRA each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
📊

Mixed cohorts — 32% veterans, 40% new entrants

■ 32% veterans ■ 28% 1-2yr ■ 40% new
Of 120 current holders: 38 (32%) held 2+ years, 34 held 1–2 years, 48 (40%) entered in the past year. Balanced distribution — some institutional memory, some recent momentum buyers.
✅

Strong quality — 20% AUM from major funds

20% from top-100 AUM funds
31 of 111 holders rank in the top 100 by AUM, accounting for 20% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
2.7
out of 10
Low Exit Risk
Exit risk score 2.7/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — NMRA

In 2026 Q1, 59 hedge funds were net buyers of NMRA (24 opened a new position, 35 added to an existing one), while 46 reduced or exited (34 trimmed, 12 sold completely) — a 56% buyer ratio, indicating a slight buying edge. Net buying has persisted for two consecutive quarters, a positive momentum signal. 20% of total institutional value in NMRA is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +12 funds (more new holders than closures). Total institutional holders: 111.

Hedge Fund Ownership: NMRA

How many hedge funds hold NMRA — quarterly history vs. share price
Quarterly hedge fund ownership of NMRA vs. share price

Market Analysis: NMRA

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: NMRA

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Neumora Therapeutics INC. (NMRA) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much NMRA has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 74d ago
NMRA
-8.7%
XLV
+4.9%

NMRA outperformed XLV by -13.6% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 29d ago
NMRA
-3.3%
XLV
+6.0%

Since the filing became public, NMRA outperformed XLV by -9.3% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

12 top-rated funds 1 high-conviction
Consensus
4.8
/ 10
breadth
×
Elite
1.0
/ 10
conviction
Hedge Fund Positioning: NMRA
111 + Investors

Track Smart Money conviction in NMRA. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 111 99 12.12%
13F Shares 73M 63M 15.91%
Total Value $141M $113M 24.87%
New Positions 24 22 +2
Increased Positions 32 33 -1
Closed Positions 12 18 -6
Reduced Positions 33 23 +10
Total Calls 6 5 20.0%
Total Puts 3 1 200.0%
PUT/CALL Ratio 0.5 0.2 Bullish

Statistics: NMRA

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

111 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in NMRA. Verified SEC 13F-HR filings.

QUARTER:
Top 25 NMRA holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Lunate Capital Ltd 3.44% 2,124,143 $4.1M
2 MIC Capital Management UK LLP 2.47% 4,460,700 $8.7M
3 Johnson & Johnson 0.55% 1,849,445 $3.6M
4 Siren, L.L.C. 0.46% 8,497,822 $16.6M
5 Stonepine Capital Management, LLC 0.39% 500,000 $975K
6 Ikarian Capital, LLC 0.20% 1,278,408 $2.5M
7 Perceptive Advisors LLC 0.19% 5,104,097 $10.0M
8 Addis & Hill, Inc 0.19% 163,386 $319K
9 Silverarc Capital Management, LLC 0.16% 818,156 $1.6M
10 ICONIQ Capital, LLC 0.11% 2,559,090 $5.0M
11 Softbank Group CORP. 0.10% 6,090,301 $11.9M
12 Velan Capital Investment Management LP 0.10% 80,000 $156K
13 Maniro Ltd 0.09% 158,231 $309K
14 WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST 0.08% 3,309,123 $6.5M
15 Stonepine Capital Management, LLC 0.08% 100,000 $195K
16 EntryPoint Capital, LLC 0.06% 110,875 $216K
17 SkyOak Wealth, LLC 0.05% 150,000 $292K
18 Tang Capital Management LLC 0.04% 439,878 $858K
19 DAFNA Capital Management LLC 0.03% 70,000 $136K
20 AlphaCore Capital LLC 0.03% 638,784 $1.2M
21 Arrowpoint Investment Partners (Singapore) Pte. Ltd. 0.03% 16,000 $31K
22 Diametric Capital, LP 0.02% 32,762 $64K
23 Catalyst Funds Management Pty Ltd 0.01% 33,300 $65K
24 RBF Capital, LLC 0.01% 90,000 $176K
25 Bridgeway Capital Management, LLC 0.01% 225,000 $439K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Neumora Therapeutics INC. (NMRA)

What does the Smart Money Trend signal show for NMRA?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added NMRA than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for NMRA?

Slight buying edge — 56% buying: Last quarter: 59 funds bought or added vs 46 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for NMRA holders?

Strong quality — 20% AUM from major funds: 31 of 111 holders rank in the top 100 by AUM, accounting for 20% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held NMRA?

Mixed — 30% long-term, 31% new: Of the 111 current holders: 33 (30%) held >2 years, 44 held 1–2 years, and 34 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Is it too late to buy Neumora Therapeutics INC. (NMRA) following the 2026 Q1 hedge fund 13F filings?

As of today, NMRA has moved -3.3% since the 2026 Q1 13F filing date (May 15, 2026), compared to +6.0% for the XLV sector ETF — an outperformance of -9.3%. Since the quarter end (March 31, 2026), NMRA has gained -8.7% vs +4.9% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →